112
Views
4
CrossRef citations to date
0
Altmetric
Original

Gastrointestinal Transit in Relation to Gut Endocrine Cells in Animal Models of Human Diabetes

Pages 23-33 | Received 21 Dec 2001, Accepted 21 May 2002, Published online: 12 Jul 2009

References

  • Abrahamsson H.: Gastrointestinal motility disorders in patients with diabetes mellitus. J. Intern. Med. 237: 403–409, 1995.
  • Allescher H.D.: Postulated physiological and pathophysiological roles on motility. In: Neuropeptides function in gastrointestinal tract (ed E.E Daniel.), pp 309–400.CRC Press, Boca Raton, 1991.
  • Ekblad E., Häkanson R. & Sundler F.: Microanatomy and chemical coding of peptide-containing neurones in the digestive tract. In: Neuropeptides function in gastrointestinal tract (ed E.E Daniel.), pp 131–180.CRC Press, Boca Raton, 1991.
  • El-Salhy M., Stenling R.& Grimelius L.: Peptidergic innervation and endocrine cells in the human liver. Scand. J. Gastroenterol. 28: 809–815, 1993.
  • El-Salhy M., Sandström 0., Näsström E., Mustajbasic M.& Zachrisson S.: Application of computer image analysis in endocrine cell quantification. Histochem. J. 29: 249–256, 1997.
  • El-Salhy M. & Spängeus A.: Antral endocrine cells in non-obese diabetic NOD-mice. Dig. Dis. Sci. 43: 1031–1037, 1998.
  • El-Salhy M., Zachrisson & Spängeus, A.: Abnormalities of small intestinal endocrine cells in non-diabetic NOD-mice. J Diabetes Complicat 12: 215–223, 1988.
  • El-Salhy M.& Sitohy B.: Abnormal gastrointestinal endocrine cells in patients with diabetes type 1: relationship to gastric emptying and myoelectrical activity. Scand. J. Gastroenterol 36: 1162–1169,2001.
  • Enck P., Rathmann W, Spiekermann M, Czemer D, Tschöpe D, Ziegler D., Strohmyer G. & Gries F.A.: Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z. Gastroenterol. 32: 637–641, 1996.
  • Feldman M. & Schiller L.R.: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann. Intern. Med. 98: 378–384, 1983.
  • Fujishima Y., Koike Y., Kaidoh T., Nishimura M. & Yoshida TO.: Restriction fragment length polymor-phism analysis of major histocompatibility complex genes in non-obese diabetic mouse strain and its sister strains. Diabetology 32: 118–125, 1989.
  • Koch K.L.: Diabetic gastropathy. Gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology and treatment. Dig. Dis. Sci. 44: 1061–1075, 1999.
  • Leiter A.B., Chey WY. & Kopin A.S.: Secretin. In: Gut peptides: biochemistry and physiology, (eds. J.H. Walsh & G.J Dockray.), pp 147–173.Raven Pres, New York, 1994.
  • Lidberg P.: On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat. Acta Physiol. Scand. Suppl 538: 1–69, 1995.
  • Locke BI G.R.: Epidemiology of gastrointestinal complications of diabetes mellitus. Eur. J. Gastroenterol. Hepatolog. 7:711-716, 1995.
  • Mannon P. & Taylor LL. Polypeptide family In: Gut peptides: biochemistry and physiology, (eds. J.H. Walsh & G.J Dockray.), pp 341–370.Raven Pres, New York, 1994.
  • Piallai,P.N. & Bharagava H.N.: The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit Peptides 5: 1055–1059, 1984.
  • Portela-Gomes GM,. Wilander E., Grimelius L., Bergstrom R. & Ruhn G. (1990). The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment. Pathol. Res. Pract: 186, 260-264, 1990.
  • Rangachari P.K.: Effects of neuropeptides on intestinal ion transport. In: Neuropeptides function in gastrointestinal tract (ed E.E Daniel.), pp 429–446.CRC Press, Boca Raton, 1991.
  • Schwartz E., Palmer M., Ingberg CM., Aman J. & Beme C. (1996). Increased prevalence of gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabetic Med. 13: 478-481, 1996.
  • Spängeus A. and El-Salhy M. (1998). Large intestinal endocrine cells in non-obese diabetic mice. J. Diabetes Complicat. 12, 321–327
  • Spängeus A. & El-Salhy M.: Gastrointestinal endocrine cells in an animal model for human type 2 diabetes. Dig. Dis. Sc.i 44: 979–985, 1999.
  • Spangeus A., El-Salhy M., Suhr 0, Eriksson J. & Lithner F.: Prevalence of gastrointestinal symptoms in young and middle-aged diabetic pathients. Scand. J. Gastroenterol. 34: 196–1202, 1999.
  • Tally N.J.: Review article: 5-Hydroxytryptamine agonists and antagonists in modulation of gastrointestinal motility and sensation: clinical implications. Aliment. Pharmacol. Ther. 6: 273–289, 1992.
  • von der Ohe MR., Hanson R.B. & Camilleri M.: Serotogenic mediation of postprandial colonic tonic and phasic response in humans. Gut 35: 536–541, 1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.